BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife”), a leading developer and supplier of bioproduction products and services, divested its wholly owned subsidiary, Savsu, LLC (“Savsu”), to Peli BioThermal LLC (“PBT”), a portfolio company of Platinum Equity, LLC.
Savsu manufactures innovative high-performance cloud-connected passive storage and transport containers enabling cold chain cloud applications for temperature-sensitive biologics and pharmaceuticals. Its offerings include the evo Smart Shipper fleet and the evoIS cloud platform, which support real-time monitoring, chain-of-custody visibility, and data integrity for critical clinical and commercial shipments. Customers include cell and gene therapy developers, pharmaceutical companies, and global logistics providers.
About Biolife Solutions
BioLife Solutions, Inc. is a leading supplier of cell processing tools and services for the CGT and broader biopharma markets. The Company’s expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution.
About Peli BioThermal LLC
Peli BioThermal is a global leader in the design and manufacturing of temperature-controlled packaging solutions, providing a broad portfolio of single-use and reusable systems that ensure the safe transport of live-saving pharmaceuticals, biologics, and cell and gene therapies. The company serves leading pharmaceutical, biotech, and clinical trial organizations across key healthcare markets with operations in North America, Europe, and Asia. The acquisition of Savsu extends Peli BioThermal’s temperature range capabilities to include cryogenic transportation, strengthening its position in key markets such as cell and gene therapy.
About Platinum Equity, LLC
Platinum Equity is a global investment firm specializing in private equity and alternative strategies, investing on behalf of institutional investors worldwide. Founded in 1995 and headquartered in Los Angeles, Platinum Equity manages approximately $50 billion in assets and has completed more than 500 acquisitions across a wide range of industries. The firm partners with businesses in sectors including finance, consumer, healthcare, industrials, media, natural resources, and technology, providing both financial and operational expertise to help companies reach their full potential.
This is the third divestiture that BioLife has retained EC M&A to support (Stirling, CBS, and now, Savsu). EC M&A has been a critical advisor to BioLife, as they have repositioned themselves toward higher-margin, recurring-revenue cell processing solutions.
EC M&A served as exclusive financial advisor to BioLife on this transaction.